Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

BMS presents new ACE/NEP inhibitors with potential in hypertension and heart failure

Feb. 18, 2003

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

Bayer identifies novel thyroid hormone-like agents with utility in arteriosclerosis

Feb. 12, 2003

Atheroprotective effects of statins

Feb. 11, 2003

Antiarrhythmic benzopyran derivatives prepared and tested at Nissan Chemical

Feb. 11, 2003

Solvay presents new antiarrhythmic potassium channel blockers

Feb. 7, 2003

New series of 5-HT6/5-HT7 ligands discovered at Sigma-Tau

Feb. 6, 2003

Aventis identifies nonpeptide, orally active Ang-(1-7) agonist

Feb. 4, 2003

New endothelin antagonists in early development at GSK

Feb. 4, 2003

Texas Biotechnology to reacquire full sitaxsentan rights

Feb. 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...